2017 ASCO Meeting: Results from the LATITUDE Study
If you have just been diagnosed with metastatic prostate cancer and your doctor wants to start you on ADT (androgen deprivation therapy, such as Lupron), which shuts off the supply...Read More
Prostate Cancer Foundation and Major League Baseball Launch Annual Home Run Challenge to Defeat Prostate Cancer
LOS ANGELES, June 1, 2017 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are launching the annual Home Run Challenge on June 1, and running through...Read More
FDA approves first precision medicine for the treatment of cancers with certain genetic defects, including prostate cancer
On May 23, 2017, the field of precision medicine achieved a major milestone with the FDA’s first ever approval of a cancer therapy based entirely on a tumor’s unique characteristics...Read More
Prostate cancer cells that commit identify fraud
A new study reported at the 2017 American Association for Cancer Research (AACR) Annual Meeting identified new mechanisms and treatment approach for an aggressive subtype of AR-therapy resistant prostate cancer....Read More
Many vs Cancer, the First Major Global Crowdfunding Initiative to Defeat Prostate Cancer, Launches Today
LOS ANGELES, May 17, 2017 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the launch of Many vs Cancer (MvC), its first global fundraising initiative that is harnessing the...Read More
Study finds genetic difference in prostate cancer in African-Americans
Dana-Farber Cancer Institute News Release May 17,2017 The genomic discovery may partly explain why prostate cancer is more aggressive in black men Scientists say more blacks and other under-represented groups...Read More
Scientists Identify Biomarkers to Guide Hormone Therapy for Prostate Cancer
University of California San Francisco News Release May 11, 2017 A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will...Read More
Advanced Prostate Cancer Treatment Failure Due to Cell Reprogramming
New York, NY (May 4, 2017)—Columbia University Medical Center (CUMC) researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to...Read More
Why has checkpoint immunotherapy been ineffective in treating prostate cancer?
Checkpoint immunotherapy, the relatively new type of cancer treatment making headlines for being able to seemingly cure some patients with melanoma and other cancers, has been notoriously ineffective in prostate...Read More
2017 AACR-Prostate Cancer Foundation Scholar-in-Training Award Recipients
The Prostate Cancer Foundation Scholar-in-Training Awards recognize promising young cancer researchers presenting outstanding proffered papers relating to advanced prostate cancer at the American Association for Cancer Research (AACR) Annual Meeting....Read More